1. Home
  2. QH vs BJDX Comparison

QH vs BJDX Comparison

Compare QH & BJDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

HOLD

Current Price

$0.93

Market Cap

1.1M

ML Signal

HOLD

Logo Bluejay Diagnostics Inc.

BJDX

Bluejay Diagnostics Inc.

HOLD

Current Price

$3.63

Market Cap

1.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QH
BJDX
Founded
2012
2015
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
1.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
QH
BJDX
Price
$0.93
$3.63
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
136.6K
94.2K
Earning Date
09-26-2025
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$357,118,848.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$55.56
P/E Ratio
$2.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$2.51
52 Week High
$169.07
$40.80

Technical Indicators

Market Signals
Indicator
QH
BJDX
Relative Strength Index (RSI) 38.31 88.93
Support Level $0.82 $0.71
Resistance Level $0.92 $3.82
Average True Range (ATR) 0.08 0.17
MACD 0.01 0.32
Stochastic Oscillator 25.95 92.78

Price Performance

Historical Comparison
QH
BJDX

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from 'sample-to-result' to help medical professionals make earlier and better triage/treatment decisions.

Share on Social Networks: